Kwast-Welfeld J, de Belle I, Walker P R, Isaacs R J, Whitfield J F, Sikorska M
Institute for Biological Sciences, National Research Council, Ottawa, Ontario, Canada.
Cancer Res. 1991 Jan 15;51(2):528-35.
We applied Southwestern and Western blotting and gel retardation techniques to investigate the changes that occur in the cyclic adenosine monophosphate (cAMP)-responsive element (CRE) binding (CREB) proteins in rapidly growing, chemically induced 5123tc and 5123D Morris hepatomas. Using the CRE sequences from the c-fos, E2A, and somatostatin gene promoters, we identified in the nuclear proteins from normal unstimulated or proliferating rat liver cells six different protein factors of Mr 34,000, 36,000, 40,000, 47,000, 56,000, and 72,000 capable of binding to the element. The Mr 47,000 protein had the highest specificity for the core CRE, suggesting its importance in cAMP-mediated gene expression. We could not find the Mr 47,000 CREB protein in the 5123tc and 5123D hepatomas. Our efforts to detect this protein in the tumors by (a) using the CRE sequence from different gene promoters, (b) altering the protocol for extracting nuclear proteins, or (c) attempting to restore its DNA-binding property by phosphorylation [with endogenous protein kinase(s), a catalytic subunit of cAMP-dependent protein kinase, and protein kinase C/dephosphorylation (with alkaline phosphatase)] were unsuccessful. The loss of tje Mr 47,000 CREB protein from solid tumors of the Morris hepatoma is likely to be related to the neoplastic properties of the tumor cell rather than to cell growth because the level of this protein remained unchanged during a 6-day period of liver regeneration. The nuclear extract from the Morris hepatoma that did not have the Mr 47,000 CRE-binding factor contained proteins immunologically related to the CREB, c-Jun, and c-Fos proteins. We conclude that the Mr 47,000 factor represents a distinct member of the CRE-binding protein family and that its absence from the hepatomas may lead to aberrant expression of cAMP-inducible genes.
我们应用蛋白质印迹法(Southwestern和Western blotting)及凝胶阻滞技术,研究在快速生长的、化学诱导的5123tc和5123D Morris肝癌中,环磷酸腺苷(cAMP)反应元件(CRE)结合蛋白(CREB)所发生的变化。利用来自c-fos、E2A和生长抑素基因启动子的CRE序列,我们在正常未受刺激或处于增殖状态的大鼠肝细胞的核蛋白中,鉴定出6种不同的蛋白因子,其分子量分别为34,000、36,000、40,000、47,000、56,000和72,000,它们能够与该元件结合。分子量为47,000的蛋白对核心CRE具有最高的特异性,表明其在cAMP介导的基因表达中具有重要作用。我们在5123tc和5123D肝癌中未发现分子量为47,000的CREB蛋白。我们试图通过以下方法在肿瘤中检测该蛋白:(a)使用来自不同基因启动子的CRE序列;(b)改变提取核蛋白的方案;或(c)尝试通过磷酸化[使用内源性蛋白激酶、cAMP依赖性蛋白激酶的催化亚基和蛋白激酶C] / 去磷酸化(使用碱性磷酸酶)来恢复其DNA结合特性,但均未成功。Morris肝癌实体瘤中分子量为47,000的CREB蛋白缺失,可能与肿瘤细胞的肿瘤特性有关,而非细胞生长,因为在肝脏再生的6天期间,该蛋白的水平保持不变。来自Morris肝癌的核提取物中没有分子量为47,000的CRE结合因子,但含有与CREB、c-Jun和c-Fos蛋白免疫相关的蛋白。我们得出结论,分子量为47,000的因子代表CRE结合蛋白家族的一个独特成员,其在肝癌中的缺失可能导致cAMP诱导基因的异常表达。